Decreased LAG3 expression on T effector cells and regulatory T cells in SAA Yingying SunChunyan LiuZonghong Shao Original Article 12 August 2020 Pages: 757 - 763
Rituximab prolongs the time to relapse in patients with immune thrombotic thrombocytopenic purpura: analysis of off-label use in Japan Masayuki KuboKazuya SakaiMasanori Matsumoto Original Article 27 August 2020 Pages: 764 - 772
High-dose dexamethasone as a replacement for traditional prednisone as the first-line treatment in children with previously untreated primary immune thrombocytopenia: a prospective, randomized single-center study Jie MaLingling FuRunhui Wu Original Article 03 September 2020 Pages: 773 - 779
Treatment outcomes of IgG4-producing marginal zone B-cell lymphoma: a retrospective case series Yuichi SumiiNoboru AsadaYoshinobu Maeda Original Article 12 August 2020 Pages: 780 - 786
Romiplostim is effective for eltrombopag-refractory aplastic anemia: results of a retrospective study Masataka IseHiromitsu IizukaKensuke Usuki Original Article 02 September 2020 Pages: 787 - 794
Close interaction with bone marrow mesenchymal stromal cells induces the development of cancer stem cell-like immunophenotype in B cell precursor acute lymphoblastic leukemia cells Kentaro KihiraVipin Shankar ChelakkotHiroki Hori Original Article 30 August 2020 Pages: 795 - 806
Dose-adjusted EPOCH with or without rituximab for aggressive lymphoma patients: real world data Shinichiro MatsudaRitsuro SuzukiJunji Suzumiya Original Article 03 September 2020 Pages: 807 - 816
Evaluation of prognosis following early disease progression in peripheral T-cell lymphoma Yasuhiro SuzukiTakahiro YanoHirokazu Nagai Original Article 04 September 2020 Pages: 817 - 824
Outcome of allogeneic hematopoietic stem cell transplantation for hypoplastic myelodysplastic syndrome Ming ZhouLiangliang WuShunqing Wang Original Article 16 August 2020 Pages: 825 - 834
Bortezomib and cyclophosphamide based chemo-mobilization in multiple myeloma Bhausaheb BagalAnant GokarnNavin Khattry Original Article 02 September 2020 Pages: 835 - 840
Use of unapproved or off-label drugs in Japan for the treatment of graft-versus-host disease and post-transplant viral infection Yachiyo KuwatsukaYoshiko AtsutaTakahiro Fukuda Original Article 01 September 2020 Pages: 841 - 850
Involvement of oral bacteria and oral immunity as risk factors for chemotherapy-induced fever with neutropenia in patients with hematological cancer Yuka SogawaMakoto FukuiDaisuke Hinode Original Article 03 September 2020 Pages: 851 - 859
Successful management of hemodialysis-dependent refractory myeloma with modified daratumumab, bortezomib and dexamethasone regimen Shinichi MizunoChigusa KitayamaToshinobu Sato Case Report 24 July 2020 Pages: 860 - 863
Lymphoplasmacytic lymphoma in a patient with Birt–Hogg–Dubé syndrome Keiji KurataHisayuki MatsumotoHironobu Minami Case Report 12 August 2020 Pages: 864 - 870
Allogeneic hematopoietic stem cell transplantation in a prior lung transplant recipient Yuki FujiwaraKen-ichi MatsuokaYoshinobu Maeda Case Report 17 August 2020 Pages: 871 - 877
A family with an MYH9-related disorder with different phenotypes masquerading as immune thrombocytopaenia: an underreported disorder in Taiwan Ying-Chih HuangYu-Hung ShihMing-Ching Shen Case Report 25 July 2020 Pages: 878 - 882
Immune thrombocytopenia in a patient with COVID-19 Emilie DeruelleOmar Ben Hadj SalemMatthieu Jamme Case Report 16 July 2020 Pages: 883 - 888
Resolution of Epstein–Barr virus-associated hemophagocytic lymphohistiocytosis associated with rapid immune reconstruction after a single course of CHOP therapy Yui ChikagawaKazuki HikishimaShinji Nakao Case Report 28 July 2020 Pages: 889 - 893
Aberrant splicing due to a novel RPS7 variant causes Diamond-Blackfan Anemia associated with spontaneous remission and meningocele Talia AkramAmbrin FatimaNiklas Dahl Case Report 09 August 2020 Pages: 894 - 899
Living-donor liver transplantation providing an adequate chemotherapy for a pediatric patient with anaplastic large cell lymphoma complicated with liver failure due to the aggravation of biliary hepatopathy by secondary hemophagocytic lymphohistiocytosis Kenichi SakamotoTomoo OsumiKimikazu Matsumoto Case Report 24 July 2020 Pages: 900 - 905
Correction to: Programmed death 1 ligand (PD-L1) in solid cancers after allogeneic hematopoietic stem cell transplantation: a retrospective analysis by the Nagasaki Transplant Group Sachie KasaiHidehiro ItonagaYasushi Miyazaki Correction 21 October 2020 Pages: 906 - 906
Retraction Note to: High-dose therapy and autologous stem cell transplantation for relapsed or high-risk diffuse large B-cell lymphoma: a nationwide survey Sung-Won KimYoshitaka AsakuraTakahiro Fukuda Retraction Note 08 October 2020 Pages: 907 - 907